 | • レポートコード：D0-MOR-AP0344 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ジフェンヒドラミンの世界市場について調査・分析した資料で、ジフェンヒドラミンの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Diphenhydramine Market is expected to register a CAGR of 2% during the forecast period. This is attributing to an increasing number of allergies worldwide. Diphenhydramine is used for the treatment of allergies and it is first line of therapy for the same. Increasing levels of indoor and outdoor pollution, changing lifestyle, poor dietary habits, rapid urbanization across the globe are few of the factors due to which allergies patients are rapidly increasing and results in boosting the overall market. As per the International Study of Asthma and Allergies in Childhood (ISAAC), a report was published in World Allergy Week Factsheet (2016) wherein an estimate of 22.1 % children of age 13 and 14 years were experienced hay fever. This high incidence of the targeted patient pool result in propelling the market to a certain extent. However, few side effects associated with consuming diphenhydramine hinder the market.
Key Market Trends
Tablets form is Estimated to Witness a Healthy Growth in Future.
Tablets is estimated to witness healthy growth in the future which is attributed to wide availability with the affordability of the drugs, low cost of manufacturing, ease of administration and convenience in storage. As these drugs are over the counter drugs which also helps in propelling the segment growth. Several advantages of tablets with an increasing number of allergic populations worldwide are among the key driver contributing to the growth of the Diphenhydramine market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Diphenhydramine Market due to increasing number of allergic populations. As per the data published by the American College of Allergy, Asthma, & Immunology, Allergies are the 6th leading cause of chronic illness in the United States and every year more than 50 million Americans suffer from allergies. Thus, increasing burden of allergic diseases is expected to aid the demand for diphenhydramine drugs and further propel the growth of the market in this region. Moreover, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The Diphenhydramine Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Cardinal Health, Pharmaceutical Associated, Bayer AG, Pfizer Inc., Johnson & Johnson, Cigna, RemedyLabs, and Fresenius Kabi among others.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing number of Allergic population
4.2.2 Increasing R&D Expendituree
4.3 Market Restraints
4.3.1 Side effects
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Dosage Forms
5.1.1 Tablets
5.1.2 Injection
5.1.3 Powder
5.1.4 Syrups
5.2 By Application
5.2.1 Allergies
5.2.2 Insomnia
5.2.3 Cold
5.2.4 Nausea
5.2.5 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cardinal Health
6.1.2 Pharmaceutical Assocaites
6.1.3 Bayer Healthcare
6.1.4 Pfizer Inc.
6.1.5 Johnson and Johnson
6.1.6 Cigna
6.1.7 Remedy Labs
6.1.8 Wan Bury
7 MARKET OPPORTUNITIES AND FUTURE TRENDS